Your browser doesn't support javascript.
loading
Three-dimensional intracardiac echocardiography for left atrial appendage sizing and percutaneous occlusion guidance.
Della Rocca, Domenico G; Magnocavallo, Michele; Gianni, Carola; Mohanty, Sanghamitra; Al-Ahmad, Amin; Bassiouny, Mohamed; Denora, Marialessia; La Fazia, Vincenzo Mirco; Lavalle, Carlo; Gallinghouse, Gerald J; Santangeli, Pasquale; Polselli, Marco; Sarkozy, Andrea; Vetta, Giampaolo; Ahmed, Adnan; Sanchez, Javier E; Pannone, Luigi; Chierchia, Gian-Battista; Tschopp, David R; de Asmundis, Carlo; Di Biase, Luigi; Lakkireddy, Dhanunjaya; Burkhardt, David J; Horton, Rodney P; Natale, Andrea.
Affiliation
  • Della Rocca DG; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 3000 N Interstate Hwy 35 Suite 720, Austin, TX, USA.
  • Magnocavallo M; Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Av. du Laerbeek 101, 1090 Jette, Brussels, Belgium.
  • Gianni C; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 3000 N Interstate Hwy 35 Suite 720, Austin, TX, USA.
  • Mohanty S; Arrhythmology Unit, Ospedale San Giovanni Calibita, Fatebefratelli Isola Tiberina-Gemelli Isola, Rome, Italy.
  • Al-Ahmad A; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 3000 N Interstate Hwy 35 Suite 720, Austin, TX, USA.
  • Bassiouny M; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 3000 N Interstate Hwy 35 Suite 720, Austin, TX, USA.
  • Denora M; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 3000 N Interstate Hwy 35 Suite 720, Austin, TX, USA.
  • La Fazia VM; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 3000 N Interstate Hwy 35 Suite 720, Austin, TX, USA.
  • Lavalle C; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 3000 N Interstate Hwy 35 Suite 720, Austin, TX, USA.
  • Gallinghouse GJ; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 3000 N Interstate Hwy 35 Suite 720, Austin, TX, USA.
  • Santangeli P; Department of Clinical, Internal, Anesthesiologist and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico 155, 00161 Rome, Italy.
  • Polselli M; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 3000 N Interstate Hwy 35 Suite 720, Austin, TX, USA.
  • Sarkozy A; Section of Cardiac Pacing and Electrophysiology, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
  • Vetta G; Arrhythmology Unit, Ospedale San Giovanni Calibita, Fatebefratelli Isola Tiberina-Gemelli Isola, Rome, Italy.
  • Ahmed A; Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Av. du Laerbeek 101, 1090 Jette, Brussels, Belgium.
  • Sanchez JE; Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Av. du Laerbeek 101, 1090 Jette, Brussels, Belgium.
  • Pannone L; Kansas City Heart Rhythm Institute, 5100 W 110th St Second Floor, Overland Park, KS, USA.
  • Chierchia GB; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 3000 N Interstate Hwy 35 Suite 720, Austin, TX, USA.
  • Tschopp DR; Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Av. du Laerbeek 101, 1090 Jette, Brussels, Belgium.
  • de Asmundis C; Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Av. du Laerbeek 101, 1090 Jette, Brussels, Belgium.
  • Di Biase L; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 3000 N Interstate Hwy 35 Suite 720, Austin, TX, USA.
  • Lakkireddy D; Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Av. du Laerbeek 101, 1090 Jette, Brussels, Belgium.
  • Burkhardt DJ; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 3000 N Interstate Hwy 35 Suite 720, Austin, TX, USA.
  • Horton RP; Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Natale A; Kansas City Heart Rhythm Institute, 5100 W 110th St Second Floor, Overland Park, KS, USA.
Europace ; 26(1)2023 Dec 28.
Article in En | MEDLINE | ID: mdl-38225176
ABSTRACT

AIMS:

Left atrial appendage (LAA) imaging is critical during percutaneous occlusion procedures. 3D-intracardiac echocardiography (ICE) features direct visualization of LAA from multiple cross-sectional planes at a time. We aimed at reporting procedural success of 3D-ICE-guided LAA occlusion and the correlation between pre-procedural transoesophageal echocardiography (TEE) and intraprocedural 3D-ICE for LAA sizing. METHODS AND

RESULTS:

Among 274 patients undergoing left atrial appendage occlusion (LAAO) with a Watchman FLX, periprocedural ICE guidance was achieved via a commercially available 2D-ICE catheter (220 patients) or a novel (NUVISION™) 3D-ICE one (54 patients). Primary endpoint was a composite of procedural success and LAA sealing at follow-up TEE. Secondary endpoint was a composite of periprocedural device recapture/resizing plus presence of leaks ≥ 3 mm at follow-up TEE. 3D-ICE measurements of maximum landing zone correlated highly with pre-procedural TEE reference values [Pearson's 0.94; P < 0.001; bias -0.06 (-2.39, 2.27)]. The agreement between 3D-ICE-based device selection and final device size was 96.3% vs. 79.1% with 2D-ICE (P = 0.005). The incidence of the primary endpoint was 98.1% with 3D-ICE and 97.3% with 2D-ICE (P = 0.99). 2D-ICE patients had a trend towards a higher incidence of periprocedural device recapture/redeployment (31.5% vs. 44.5%; P = 0.09). The secondary endpoint occurred in 31.5% of 3D-ICE patients vs. 45.9% of 2D-ICE ones (P = 0.065).

CONCLUSION:

Intracardiac echocardiography-guided LAAO showed a very high success, with no major adverse events. A very high level of agreement for LAA sizing was found between pre-procedural TEE and periprocedural 3D-ICE. 3D-ICE performed significantly better than 2D-ICE for FLX size selection and may provide better guidance during device deployment.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Atrial Appendage Type of study: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Humans Language: En Journal: Europace Journal subject: CARDIOLOGIA / FISIOLOGIA Year: 2023 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Atrial Appendage Type of study: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Humans Language: En Journal: Europace Journal subject: CARDIOLOGIA / FISIOLOGIA Year: 2023 Document type: Article Affiliation country: United States